Equity Analysis /
United States of America

US : Biotechnology - Biotechnology | Takeaways From Our KOL Panel on Emerging Sickle Cell Disease Therapeutics

    Dane Leone
    Contributors
    Danielle Brill
    Steven Seedhouse
    CGS-CIMB
    18 May 2022
    Published by